Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the appointment of Monica Noether to a new role as leader of an expanded health care offering at CRA. Dr. Noether has decided to return to a full-time consulting role at the firm and will step down from her roles as Chief Operating Officer (COO) and Executive Vice President (EVP) effective today. CRA does not intend to fill the COO and EVP role at this time.
“Monica has been very effective in shaping our global consulting operations and administrative functions during the past three years as our Chief Operating Officer,” said CRA's President and Chief Executive Officer Paul Maleh. “Monica’s new role is ideally suited for her consulting and management expertise, and I am looking forward to her leadership of CRA’s health care offering. Few surpass Monica’s knowledge and understanding of our organization, and her imprint on CRA is far-reaching. Prior to becoming COO, Monica spent nearly 15 years leading CRA’s various litigation-related business units, as well as building a highly successful consulting practice as a leading expert in health care antitrust and reimbursement economics.”
“This opportunity juxtaposes my passions for analytical consulting and health care, as well as for advancing CRA’s commitment to both the highest quality client offerings and rewarding careers,” said Dr. Monica Noether. “Major changes in the health care sector are affecting all of its players—providers, payors, suppliers, and the agencies that regulate them. Given this sector’s importance in our economy, it is the ideal time to diversify CRA’s health care offering to clients and more widely leverage our robust understanding of health care markets with our unsurpassed expertise in complex, empirically based analyses. CRA maintains an entrepreneurial culture that provides multiple paths to advance within the Company, and I am excited to begin this next opportunity.”
CRA has been a leader in antitrust, finance, and other economic issues related to the health care industry for more than 15 years, providing economic testimony on these matters. The firm’s expanded health care offering will build upon its established reputation in litigation and regulatory support, drawing on experts across CRA, to provide a comprehensive service that addresses issues surfacing from private and public sector health care reform, including in antitrust, reimbursement, valuation, finance, intellectual property, and false claims.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts